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Abstract 
Background: A decrease in circulating lymphocytes has been described as a marker of poor prognosis after septic 
shock; however, scarce data are available after cardiac arrest (CA). The aim of this study was to evaluate the impact of 
lymphopaenia after successful cardiopulmonary resuscitation.
Methods: This is a retrospective analysis of an institutional database including all adult CA patients admitted to the 
intensive care unit (ICU) between January 2007 and December 2014 who survived for at least 24 h. Demographic, CA‑
related data and ICU mortality were recorded as was lymphocyte count on admission and for the first 48 h. A cerebral 
performance category score of 3–5 at 3 months was considered as an unfavourable neurological outcome.
Results: Data from 377 patients were analysed (median age: 62 [IQRs: 52–75] years). Median time to return of spon‑
taneous circulation (ROSC) was 15 [8–25] min and 232 (62%) had a non‑shockable initial rhythm. ICU mortality was 
58% (n = 217) and 246 (65%) patients had an unfavourable outcome at 3 months. The median lymphocyte count on 
admission was 1208 [700–2350]/mm3 and 151 (40%) patients had lymphopaenia (lymphocyte count <1000/mm3). 
Predictors of lymphopaenia on admission were older age, a shorter time to ROSC, prior use of corticosteroid therapy 
and high C‑reactive protein levels on admission. ICU non‑survivors had lower lymphocyte counts on admission than 
survivors (1100 [613–2317] vs. 1316 [891–2395]/mm3; p = 0.05) as did patients with unfavourable compared to those 
with favourable neurological outcomes (1100 [600–2013] vs. 1350 [919–2614]/mm3; p = 0.003). However, lympho‑
paenia on admission was not an independent predictor of poor outcomes in the entire population, but only among 
OHCA patients.
Conclusions: A low lymphocyte count is common in CA survivors and is associated with poor outcome after OHCA.
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Background
Despite the high mortality rates still associated with 
sudden cardiac arrest (CA), advances have been made 
in recent years, in particular to improve the proportion 
of patients achieving return of spontaneous circula-
tion (ROSC) after cardiopulmonary resuscitation (CPR) 
[1]. Although the implementation of high-quality CPR 
and early defibrillation has increased the number of CA 
patients being admitted to the hospital, there has been 
no associated increase in survival rates and neurologi-
cal recovery among CA survivors [2, 3]. The high mor-
tality rate observed in this patient population is related 
to the consequences of the global ischaemia–reperfu-
sion process, the so-called post-cardiac arrest syndrome 
(PCAS), which is characterised by a systemic inflamma-
tory response that may be involved in the development of 
myocardial dysfunction, brain injury and multiple organ 
failure [3, 4].
The PCAS is a complex pathophysiological process, 
which encompasses a generalised activation of immuno-
logical and coagulation pathways and has many features 
common with sepsis [4]. Adrie et  al. [4] reported a sig-
nificant increase in the concentrations of various serum 
cytokines in CA patients in the first hours after the initial 
injury, which was more significant in non-survivors than 
in survivors. Other studies have also shown impaired 
microcirculatory perfusion and increased plasma endo-
toxin levels in CA patients, similar to findings in sepsis 
Open Access
*Correspondence:  ftaccone@ulb.ac.be 
1 Department of Intensive Care, Erasme Hospital, Université Libre de 
Bruxelles (ULB), Route de Lennik, 808, 1070 Brussels, Belgium
Full list of author information is available at the end of the article
Page 2 of 10Villois et al. Ann. Intensive Care  (2017) 7:85 
[5, 6]. Interestingly, sepsis is rapidly accompanied by a 
state of relative immunosuppression, characterised by a 
reduction in the number of functional immune cells and 
T-cell dysfunction [7, 8], which predicts a poor outcome 
[9].
Among the different components of the immune 
response, lymphocytes are essential in the organism’s 
defence against external aggression, by interaction (T 
cells) with antigen-presenting cells and subsequent 
activation of the immune response (B and T cells), in a 
complex interplay of cell-to-cell interactions, produc-
tion of adhesion molecules and modulation of growth 
factors [10]. Severe lymphopaenia has been described in 
almost 30% of patients admitted to the intensive care unit 
(ICU) with severe sepsis or septic shock and was associ-
ated with high plasma levels of tumour necrosis factor-α, 
interleukin (IL)-6 and IL-10 [11]. Lymphopaenia dur-
ing sepsis was also associated with features of immuno-
suppression, such as spontaneous hypothermia and an 
increased risk of hospital-acquired infections, and was 
an independent predictor of poor outcome [9, 12]. Per-
sistent lymphopaenia has also been associated with poor 
outcomes in trauma patients, in particular when an infec-
tion occurred during the hospital stay [13]. Although sur-
vivors from CA are at high risk of secondary infections, 
in particular early-onset pneumonia [14], no data are 
available on the relationship between lymphocyte count 
and the risk of infection or patient outcome. Thus, the 
aim of our study was to evaluate the prevalence of lym-
phopaenia among CA survivors and its association with 
ICU survival and long-term neurological outcome. We 
hypothesised that lymphopaenia could be a significant 
predictor of poor outcome in this setting.
Methods
Study population
This study was performed in the Department of Intensive 
Care at Erasme Hospital. All comatose patients (Glasgow 
Coma Scale [GCS] score <9) admitted after in-hospital 
(IHCA) or out-of-hospital (OHCA) CA and surviving for 
at least 24 h after the arrest were included in an institu-
tional database (January 2007–December 2014) and con-
sidered as eligible for the study. Exclusion criteria were 
missing data for blood count or lymphocyte count on 
admission.
Post‑resuscitation care
All comatose CA patients were treated with targeted 
temperature management (TTM; target body tempera-
ture 32–34 °C) for 24 h, according to a standardised insti-
tutional protocol. Cooling was started immediately after 
hospital admission using a bolus of cold fluid (in general 
saline solutions, given as a dose of 20–30  mL/kg over 
30  min) and a water-circulating blanket device (Medi-
Therm II, Gaymar, USA, or Arctic Sun, Bard, France). 
Sedation and analgesia consisted of midazolam and mor-
phine, which were adjusted to obtain deep sedation (e.g. 
severe depression of consciousness during which patients 
cannot be aroused with repeated or painful stimulation); 
cisatracurium was administered to control shivering 
in the induction phase (bolus of 0.15  mg/kg) and then 
given, if needed, by continuous infusion (1–3  mcg/kg/
min). Rewarming (<0.5 °C/h) was achieved passively, and 
sedation/analgesia was discontinued at normothermia 
(>37 °C).
Patients were kept in a 30° semi-recumbent posi-
tion; ventilation was set to target  PaCO2 between 35 
and 45  mmHg and  SpO2 >94%. Blood glucose was kept 
between 110 and 150  mg/dL using a local protocol 
for continuous insulin infusion; enteral nutrition was 
allowed. Mean arterial pressure was maintained at least 
above 65 mmHg using volume resuscitation, noradrena-
line and/or dobutamine, when needed. Intra-aortic 
balloon counterpulsation (IABP) or extracorporeal mem-
brane oxygenation (ECMO) was also used in severe car-
diogenic shock.
Data collection
We collected data on demographics, pre-existing chronic 
diseases and immunosuppressive treatment, and CPR 
(initial rhythm, bystander CPR, time to ROSC, total 
adrenaline dose) in all patients. A complete blood count, 
including neutrophil and lymphocyte cell counts, and 
C-reactive protein (CRP) concentration were recorded 
on ICU admission and during the first 48  h. We also 
recorded the use of any other immunosuppressive drugs, 
vasopressors, mechanical ventilation and continuous 
renal replacement therapy (CRRT) during the ICU stay. 
Lactate concentrations were also collected on admission. 
The development of infections during the ICU stay was 
recorded; survival was recorded at ICU discharge and 
ICU length of stay was noted. Neurological evaluation at 
3 months after CA was assessed using the cerebral per-
formance category score (CPC; 1  =   no or mild neuro-
logical disability, 2   =   moderate neurological disability, 
3   =   severe neurological impairment, 4   =   vegetative 
state, 5  =  death). The CPC evaluation was assessed dur-
ing follow-up visits or by telephone interview with the 
general practitioner.
Definitions
Lymphopaenia was defined as an absolute lymphocyte 
count of <1000/mm3 cells; severe lymphopaenia was 
defined as an absolute lymphocyte count of <500/mm3 
cells [15]. Patients were subsequently divided into four 
groups according to the lymphocyte levels during the 
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study period: “group 1” included patients with persistent 
lymphopaenia throughout the 48  h; “group 2” included 
patients with lymphopaenia on admission but with nor-
mal lymphocyte counts at 48 h; “group 3” included those 
who had normal lymphocyte counts throughout the 48-h 
study period; and “group 4” included those with normal 
lymphocyte counts on admission but who had developed 
lymphopaenia by 48 h.
Favourable 3-month neurological outcome was defined 
as a CPC of 1–2 at 3 months and unfavourable neurologi-
cal outcome as a CPC of 3–5. The diagnosis of infection 
was made according to the CDC/NHSN criteria [16]. 
Acute kidney injury (AKI) was defined as a daily urine 
output <0.5  mL/kg/h and/or an increase in serum cre-
atinine level by at least 0.3 mg/dL or >1.5 times increase 
from baseline values, as previously reported [17]. Shock 
was defined as the need for vasopressor agents for more 
than 6 h.
Statistical analysis
Statistical analyses were performed using the SPSS 24.0 
for Windows NT software package (SPSS Inc, Chicago, 
IL, USA). Descriptive statistics were computed for all 
study variables. The Kolmogorov–Smirnov test was used 
and histograms and normal-quantile plots were exam-
ined to verify the normality of distribution of continuous 
variables. Discrete variables were expressed as counts 
(percentage) and continuous variables as means   ±   SD 
or median (25th to 75th percentiles). Demographics and 
clinical differences between groups were assessed using 
the Chi-square test, Fisher’s exact test, Student’s t test 
or Mann–Whitney U test, as appropriate. The signifi-
cance of differences among the four groups was analysed 
using two-way (time and group) analysis of variance for 
repeated measures (ANOVA), followed by Bonferroni 
post hoc analysis. Multivariable logistic regression anal-
ysis with lymphopaenia on admission as the depend-
ent variable was performed in all patients; co-linearity 
between variables was excluded prior to modelling; only 
variables associated with a higher risk of ICU mortal-
ity (p < 0.2) on a univariate basis were introduced in the 
multivariable model. Odds ratios (OR) with 95% confi-
dence intervals (CI) were computed. The same analysis 
was then performed to identify independent predictors 
of survival and neurological outcome and for all meas-
ured outcome considering only IHCA or OHCA patients. 
Also, an additional analysis on the independent predic-
tors of lymphopaenia on admission with the exclusion of 
patients under corticosteroids or other immunosuppres-
sive therapies was performed. A p value <0.05 was con-
sidered as statistically significant.
Results
Of the 424 eligible patients admitted during the study 
period, 23 died within the first 24 h and 24 were excluded 
for missing data, so that 377 were included in the final 
analysis. The main characteristics of the study population 
(age 62 [52–72] years—OHCA 56%) are given in Table 1. 
Median time to ROSC was 15 min and 232 (62%) patients 
had a non-shockable initial rhythm; 150 (40%) patients 
had a non-cardiac origin of arrest. ICU mortality was 
58% (n =  217) and 131 patients (38%) had a favourable 
neurological outcome.
Lymphocyte count
The median white blood cell count on the day of admis-
sion was 12,200 [8700–16,775]/mm3, including a 
lymphocyte count of 1100 [600–2208]/mm3. The lym-
phocyte count was lower in patients previously treated 
with immunosuppressive agents (n  =  88) compared to 
the other patients (800 [445–1989]/mm3 vs. 1290 [765–
2439]/mm3; p = 0.004), in patients with IHCA compared 
to those with OHCA (946 [583–1450]/mm3 vs. 1637 
[900–3120]/mm3; p  <  0.001) and in patients with non-
shockable rhythms compared to those with shockable 
rhythms (1055 [601–2078]/mm3 vs. 1520 [950–3060]/
mm3; p < 0.001—Fig. 1).
When grouped according to the change in lympho-
cyte count during the 48-h period, 112 patients (30%) 
were in group 1, 39 (25%) in group 2, 86 (23%) in group 
3 and 140 (37%) in group 4. The proportions of patients 
receiving immunosuppressive therapy, of non-survivors, 
of patients with unfavourable outcome and of patients 
developing an infection during the ICU stay were signifi-
cantly higher in group 1 than in the other groups (Fig. 2).
Lymphopaenia
A total of 151 (40%) patients had lymphopaenia, which 
was severe in 48 patients. Patients with lymphopaenia 
on admission were older, had a shorter time to ROSC 
and were more likely to have had IHCA, a non-cardiac 
aetiology of CA, bystander CPR and a non-shockable 
initial rhythm than patients without lymphopaenia 
(Table  1). Comorbid hypertension, diabetes and immu-
nosuppressive therapy were more common in patients 
with lymphopaenia than in those without. Patients with 
lymphopaenia on admission also had a lower neutrophil 
count and haemoglobin concentration on admission and 
higher CRP concentrations. Lymphopaenic patients more 
often developed an infection and AKI during the study 
period and more frequently required vasopressors and 
CRRT.
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Lymphopaenia, survival and neurological outcome
ICU non-survivors had a lower lymphocyte count on 
admission than ICU survivors (1100 [613–2317]/mm3 
vs. 1316 [891–2395]/mm3; p = 0.048). The non-survivors 
were older, more frequently had unwitnessed CA, had 
a longer time to ROSC and had a higher occurrence of 
Table 1 Characteristics of study population according to the presence of lymphopaenia on admission
CA cardiac arrest, CPR cardiopulmonary resuscitation, ROSC return of spontaneous circulation, COPD chronic obstructive pulmonary disease, IABP intra-aortic 
balloon pump counterpulsation, ECMO extracorporeal membrane oxygenation, CRRT continuous renal replacement therapy, ICU intensive care unit, HIV human 
immunodeficiency virus
All (n = 377) Lymphopaenia (n = 151) No lymphopaenia (n = 226) p value
Age (years) 62 [52–75] 69 [54–78] 59 [51–71] <0.001
Weight (kg) 76 [67–85] 75 [67–82] 77 [67–88] 0.22
Male, n (%) 263 (70) 105 (70) 158 (70) 0.51
Witnessed CA, n (%) 318 (84) 132 (87) 186 (82) 0.12
Bystander CPR, n (%) 249 (66) 110 (73) 139 (62) 0.02
Time to ROSC (min) 15 [8–25] 10 [5–21] 18 [10–27] <0.001
Adrenaline (mg) 3 [2–6] 3 [1–5] 4 [2–7] <0.001
Out‑of‑hospital CA, n (%) 211 (56) 60 (40) 151 (67) <0.001
Cardiac origin of arrest, n (%) 227 (60) 80 (53) 147 (65) 0.01
Shockable rhythm, n (%) 145 (38) 41 (27) 104 (46) <0.001
Comorbidities
 Chronic heart failure, n (%) 81 (21) 37 (25) 44 (19) 0.15
 Hypertension, n (%) 171 (45) 78 (52) 93 (41) 0.03
 Coronary artery disease, n (%) 164 (44) 62 (41) 102 (45) 0.25
 Diabetes, n (%) 92 (24) 48 (32) 44 (19) 0.01
 COPD/asthma, n (%) 66 (18) 31 (21) 35 (15) 0.13
 Neurological disease, n (%) 64 (17) 31 (21) 32 (14) 0.05
 Chronic renal disease, n (%) 67 (18) 36 (24) 31 (14) 0.008
 Liver cirrhosis, n (%) 22 (6) 14 (9) 8 (4) 0.02
 HIV, n (%) 1 (0) 1 (1) 0 0.40
 Corticosteroid therapy, n (%) 73 (19) 41 (27) 32 (14) 0.001
 Other immunosuppressive agents, n (%) 15 (4) 11 (7) 4 (2) 0.008
Initial blood analysis
 White blood cells count (/mm3) 12,200 [9000–16,700] 10,700 [7700–14,500] 13,100 [9925–17,475] 0.06
 Neutrophils (/mm3) 9400 [6300–13,500] 9100 [6500–13,200] 9915 [5947–13,700] <0.001
 Haemoglobin (g/dL) 12.0 [9.9–13.7] 10.6 [8.9–12.9] 12.8 [10.8–14.1] 0.04
 Platelets (*103/mm3) 193 [127–264] 158 [100–230] 210 [147–285] <0.001
 C‑reactive protein (mg/dL) 9 [2–52] 29 [4–93] 5 [2–22] <0.001
 Lactate (mEq/L) 4.3 [2.8–7.9] 4.1 [2.6–7.8] 4.5 [2.9–7.9] 0.20
During ICU stay
 Infection, n (%) 215 (57) 100 (66) 115 (51) 0.002
 IABP, n (%) 27 (7) 6 (4) 21 (9) 0.04
 ECMO, n (%) 51 (14) 23 (15) 28 (12) 0.26
 Shock, n (%) 205 (54) 90 (60) 115 (51) 0.06
 Acute kidney injury, n (%) 228 (60) 100 (66) 128 (57) 0.04
 CRRT, n (%) 57 (15) 30 (20) 27 (12) 0.03
 Vasopressor therapy, n (%) 274 (73) 120 (79) 154 (68) 0.01
 Dobutamine therapy, n (%) 200 (53) 85 (56) 115 (51) 0.18
Outcomes
 Total ICU stay (days) 4 [2–8] 4 [2–8] 4 [2–8] 0.93
 ICU mortality, n (%) 217 (58) 95 (63) 122 (54) 0.05
 Hospital mortality, n (%) 235 (62) 103 (68) 132 (58) 0.03
 Favourable outcome at 3 months, n (%) 131 (35) 43 (28) 88 (39) 0.02
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non-cardiac origin of arrest and non-shockable rhythms 
than survivors (Table  2). Non-survivors had higher 
lactate levels on admission and more frequently had 
shock or AKI during the ICU stay than survivors. These 
patterns were similar in patients with unfavourable com-
pared to those with favourable outcomes (Table 2).
Multivariable analyses to predict lymphopaenia
In a multivariable logistic regression analysis, older age, 
a shorter time to ROSC, comorbid use of corticosteroid 
therapy and high CRP levels on admission were inde-
pendently associated with the presence of lymphopae-
nia on admission (Table  3); IHCA was not associated 
with the occurrence of lymphopenia (OR 1.741 [−3.032 
to 49.710]; p  =  0.083). In IHCA patients, older age, a 
shorter time to ROSC, high white blood cells count and 
CRP levels on admission and the use of corticosteroids 
were independently associated with the presence of lym-
phopaenia on admission (Additional file  1: Supplemen-
tal Tables  1 and 5). In OHCA patients, a shorter time 
to ROSC, high white blood cells and CRP levels as well 
as low platelet count on admission were independently 
associated with the presence of lymphopaenia on admis-
sion (Additional file  1: Supplemental Tables  1 and 5). 
Finally, older age, a shorter time to ROSC, the presence 
of a non-shockable rhythm, high white blood cells count 
and CRP levels or low platelets count on admission and 
the use of corticosteroids were independently associated 
with the presence of lymphopaenia on admission in those 
patients without corticosteroids or immunosuppressive 
therapy (Additional file 1: Supplemental Tables 4 and 8).
Multivariable analyses to predict ICU mortality
Using the same statistical approach, older age, the 
absence of bystander CPR, a non-shockable initial 
rhythm, a non-cardiac aetiology of the arrest, high blood 
lactate levels on admission and the use of vasopressors 
were independent predictors of ICU mortality (Table 4), 
but lymphopaenia was not (OR 1.367 [0.787–2.567; 
p  =  0.26). In IHCA patients, the absence of bystander 
CPR, a non-shockable rhythm, high epinephrine dose 
and the development of shock were independently asso-
ciated with ICU mortality (Additional file 1: Supplemen-
tal Tables  2, 6 and 7), but not lymphopaenia (OR 1.319 
[0.708–2.458]; p  =  0.38). In OHCA patients, older age, 
the absence of bystander CPR, a non-cardiac origin of the 
arrest, a non-shockable rhythm and high blood lactate 
levels on admission were independent predictors of ICU 
mortality (Additional file 1: Supplemental Tables 3, 6 and 
7); lymphopaenia was not associated with ICU mortality 
(OR 1.912 [0.876–3.621]; p = 0.09).
Multivariable analyses to predict poor long‑term 
neurological outcome
In the multivariable analysis, older age, the absence of 
bystander CPR and a non-shockable initial rhythm were 
independent predictors of an unfavourable neurological 
Fig. 1 Differences in lymphocyte counts on admission among 
survivors versus non‑survivors; patients with favourable (FO) versus 
unfavourable neurological outcome (UO); patients receiving immu‑
nosuppressive agents (IS+) versus others (IS−); patients with in‑
hospital (IHCA) versus out‑of‑hospital cardiac arrest (OHCA); patients 
with shockable rhythms (VF/VT) versus others (no VF/VT); patients 
who developed infection versus those without infection. Data are 
presented as median and 25th (lower limit) and 75th percentiles 
(upper limit). *p < 0.05 for lymphocyte count
Fig. 2 Proportion of patients on immunosuppressive therapy, devel‑
oping infections, non‑survivors and with favourable neurological 
outcome (FO) according to the different groups of lymphocyte levels 
over the first 48 h after arrest: “group 1” included patients with persis‑
tent lymphopaenia throughout the 48 h; “group 2” included patients 
with lymphopaenia on admission but with normal lymphocyte 
counts at 48 h; “group 3” included those who had normal lymphocyte 
counts throughout the 48‑h study period; and “group 4” those with 
normal lymphocyte counts on admission but who had developed 
lymphopaenia by 48 h
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outcome (Table  4); lymphopaenia was not significantly 
associated with unfavourable outcome either (OR 1.228 
[0.723–3.167; p = 0.28). In IHCA patients, the absence of 
bystander CPR and a non-shockable rhythm were inde-
pendently associated with UO (Additional file  1: Sup-
plemental Tables 2, 6 and 7), but not lymphopaenia (OR 
1.219 [0.719–2.973]; p = 0.36). In OHCA patients, older 
age, a non-cardiac origin of the arrest, lymphopaenia on 
admission and high epinephrine doses were independ-
ent predictors of UO (Additional file  1: Supplemental 
Tables 3, 6 and 7).
Discussion
In this study, 40% of post-CA patients had lymphopae-
nia, and in one-third of them, this persisted through the 
first 48 h after admission. Predictors of lymphopaenia on 
Table 2 Characteristics of study population according to ICU survival and long-term neurological outcome
CA cardiac arrest, CPR cardiopulmonary resuscitation, ROSC return of spontaneous circulation, COPD chronic obstructive pulmonary disease, IABP intra-aortic 
balloon pump counterpulsation, ECMO extracorporeal membrane oxygenation, CRRT continuous renal replacement therapy, ICU intensive care unit, HIV human 
immunodeficiency virus
* p < 0.05 in survivors versus non-survivors OR favourable versus unfavourable outcome
ICU survivors (n = 160) ICU non‑survivors (n = 217) Favourable outcome 
(n = 131)
Unfavourable outcome 
(n = 246)
Age (years) 59 [49–71] 66 [54–78]* 58 [50–70] 66 [53–77]*
Weight (kg) 77 [70–85] 75 [65–85] 78 [70–85] 75 [65–85]
Male, n (%) 118 (74) 145 (67) 97 (74) 166 (67)
Witnessed CA, n (%) 144 (90) 174 (80)* 118 (90) 200 (80)*
Bystander CPR, n (%) 122 (76) 127 (59)* 101 (77) 148 (60)*
Time to ROSC (min) 12 [5–20] 18 [10–25]* 12 [5–20] 17 [10–25]*
Adrenaline (mg) 2 [1–4] 4 [2–7]* 2 [1–4] 4 [2–6]*
Out‑of‑hospital CA, n (%) 86 (54) 125 (57) 74 (56) 137 (56)
Cardiac origin of arrest, n (%) 110 (69) 117 (54)* 102 (78) 133 (54)*
Shockable rhythm, n (%) 89 (56) 56 (26)* 82 (63) 63 (26)*
Comorbidities
 Chronic heart failure, n (%) 33 (21) 48 (22) 27 (21) 54 (22)
 Hypertension, n (%) 76 (48) 95 (44) 60 (46) 111 (45)
 Coronary artery disease, 
n (%)
67 (42) 97 (45) 54 (41) 110 (45)
 Diabetes, n (%) 35 (22) 57 (26) 25 (19) 67 (27)
 COPD/asthma, n (%) 26 (16) 40 (18) 19 (15) 47 (19)
 Neurological disease, n (%) 22 (14) 42 (19) 13 (10) 51 (21)*
 Chronic renal disease, n (%) 26 (16) 41 (19) 20 (15) 47 (19)
 Liver cirrhosis, n (%) 7 (4) 15 (7) 4 (3) 18 (7)
 HIV, n (%) 1 (1) – 1 (1) –
 Corticosteroid therapy, n (%) 25 (16) 48 (22) 20 (15) 53 (22)
 Immunosuppressive agents, 
n (%)
5 (3) 10 (5) 3 (2) 12 (5)
 Lactate on admission 
(mEq/L)
3.8 [2.4–5.7] 4.9 [3.2–8.7]* 3.9 [2.5–5.7] 4.6 [3–8.5]*
During ICU stay
 Infection, n (%) 105 (66) 110 (51)* 83 (63) 132 (54)
 IABP, n (%) 9 (6) 18 (8) 7 (5) 20 (8)
 ECMO, n (%) 19 (12) 32 (15) 18 (14) 33 (13)
 Shock, n (%) 68 (43) 137 (63)* 58 (44) 147 (60)*
 Acute kidney injury, n (%) 81 (51) 147 (68)* 65 (50) 163 (66)*
 CRRT, n (%) 23 (14) 34 (16) 19 (15) 38 (15)
 Vasopressor therapy, n (%) 99 (62) 175 (81)* 81 (62) 193 (78)*
 Dobutamine therapy, n (%) 81 (51) 119 (55) 66 (50) 134 (54)
 Total ICU stay 6 [3–11] 2 [2–5]* 5 [3–11] 3 [2–5]*
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admission were older age, a shorter resuscitation time, 
a history of corticosteroid therapy and high levels of the 
inflammatory marker (e.g. CRP). Lymphopaenia was more 
frequent in patients with poor outcome but was not an 
independent predictor of mortality or unfavourable neuro-
logical outcome, unless in the subgroup of OHCA patients.
The occurrence of lymphopaenia and its impact on sur-
vivors of CA has not been well studied. In a pig model of 
prolonged CA and CPR, Gu et al. reported a high degree 
of splenic lymphocyte apoptosis, which was initiated by 
activation of the Bcl-2/Bax mitochondrial pathway [18]. 
These authors also described a reduction in  CD4+/CD8+ 
T lymphocytes and a shift in these cells from an anti-
inflammatory (Th-2) to a pro-inflammatory (T-helper 
[Th]-1) state in the myocardium [19, 20]. In mice submit-
ted to global cerebral ischaemia secondary to CA within 
3 h after resuscitation, Deng et al. [21] showed the pres-
ence of infiltrating peripheral  CD4+ T lymphocytes in 
the brain. These experimental data indicate that early 
disturbances of immunological function after ROSC are 
associated with an increased production of inflamma-
tory mediators and lymphocyte apoptosis, as well as an 
intense cardiac and neuroimmune response in which 
infiltrating T cells may play a key role. Few data are avail-
able in humans. In 50 OHCA patients, Venet et  al. [22] 
reported a moderate decrease in the number of circu-
lating  CD4+ T lymphocytes although total lymphocyte 
count was normal. Nevertheless, the high mortality rate in 
that study (90%) prevented a comparison of lymphocyte 
levels in survivors and non-survivors. Indeed, as clinical 
studies have demonstrated that PCAS is characterised by 
high plasma cytokine and endotoxin levels, future studies 
should better characterise how these abnormalities may 
alter lymphocyte sub-populations and function in CA 
survivors and whether these changes are reversible or can 
be influenced by therapeutic interventions [23, 24].
Lymphopaenia has been widely described in patients 
with sepsis [12, 25, 26]. After an initial predominant 
Table 3 Multivariable regression analysis to identify inde-
pendent predictors of lymphopaenia on admission
Hosmer and Lemeshow goodness-of-fit test Chi-squared = 4.93 (p = 0.76). This 
model has a 69% correct classification (48% for lymphopenia and 83% for non-
lymphopenia)
ROSC return of spontaneous circulation, CRP C-reactive protein
Lymphopaenia on admission
p value OR 95% CI for OR
Lower Upper
Age (years) 0.012 1.023 1.005 1.042
Time to ROSC (min) 0.001 0.960 0.936 0.984
Previous corticosteroid therapy 0.048 2.040 1.007 4.131
CRP (mg/dL) 0.007 1.005 1.002 1.009
Table 4 Multivariable regression analysis to  identify independent predictors of  ICU mortality and unfavourable neuro-
logical outcome at 3 months after cardiac arrest
ICU mortality: Hosmer and Lemeshow goodness-of-fit test Chi-squared = 5.16 (p = 0.23). This model has a 71% correct classification (57% for survivors and 81% for 
non-survivors)
Neurological outcome: Hosmer and Lemeshow goodness-of-fit test Chi-squared = 9.18 (p = 0.33). This model has a 73% correct classification (48% for good 
neurological outcome and 82% for poor neurological outcome)
CPR cardiopulmonary resuscitation
ICU mortality
p value OR 95% CI for OR
Lower Upper
Age (years) 0.001 1.042 1.033 1.055
Bystander CPR 0.006 0.441 0.218 0.755
Non‑cardiac aetiology 0.015 2.069 1.345 4.568
Non‑shockable rhythm 0.001 2.687 1.876 4.325
Vasopressor use 0.02 2.142 1.356 8.567
Lactate on admission (mEq/L) 0.003 1.113 1.096 1.301
Unfavourable neurological outcome
p value OR 95% CI for OR
Lower Upper
Age (years) 0.001 1.032 1.024 1.057
Bystander CPR 0.008 0.337 0.219 0.785
Non‑shockable rhythm <0.001 2.177 1.765 3.987
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pro-inflammatory phase, many septic patients develop 
persistent immunosuppression, characterised by 
increased inhibitory receptors on T cells and antigen-pre-
senting cells, decreased production of pro-inflammatory 
cytokines, expansion of myeloid-derived suppressor cells, 
and apoptosis-related loss of T and B-lymphocytes and 
dendritic cells [7, 27]. Induction of lymphocyte apoptosis 
increased mortality and prevented bacteraemic control in 
septic animals [28]. The detrimental effects of apoptosis 
are not only related to the severe loss of immune cells but 
also the impact that apoptotic cell uptake has on the sur-
viving immune cells. As such, uptake of apoptotic cells 
by monocytes, macrophages and dendritic cells results 
in immune tolerance and cellular anergy, which is associ-
ated with increased IL-10 production and the induction 
of a Th-2 cell immune phenotype; the net result of these 
changes is that the surviving phagocytic cells cannot pro-
vide adequate defence against infection [29].
In our study, patients with lymphopaenia were older 
than those without. Lymphopaenia is a common find-
ing in elderly hospitalised patients and has been associ-
ated with poor outcome in these patients [30]. There is a 
significant interaction between the immune system and 
the ageing process, which may also influence the occur-
rence of chronic diseases; in particular, thymic demise 
represents an important phenomenon that can cause a 
reduction in T-cell count and peripheral proliferation 
of pre-existing T-cell clones, which can trigger limited 
immune reactivity damage-associated molecular patterns 
[31]. As expected, previous therapy with corticosteroids 
was also an independent determinant of lymphopaenia 
[32]. Data on the prevalence of lymphopaenia among cor-
ticosteroid users are scarce and biased by the presence of 
concomitant malignancies, administration of chemother-
apy or other immunosuppressive drugs. The mechanisms 
include increased Th-2 cells with reduction in pro-inflam-
matory circulating cytokines or externalisation of phos-
phatidylserine, which may trigger cellular apoptosis, in 
particular of  CD4+ cells [33]. Nevertheless, we found an 
association between increasing CRP levels and the risk of 
lymphopaenia. This is probably due to increased produc-
tion of IL-6, which has been shown to be an independent 
predictor of poor outcome in CA patients [34]. In a recent 
study, the injection of endotoxin in healthy volunteers was 
associated with systemic inflammation, which triggered 
the occurrence of lymphopaenia, by an increase in anti-
inflammatory regulatory T cells and a relative functional 
impairment of T-cell cytokine production, despite detect-
able levels of plasma pro-inflammatory cytokines [35]. 
Predictors of lymphopaenia in patients without previous 
immunosuppressive therapy were similar to those of the 
entire cohort, underlying again their relevance indepen-
dently of patients’ immune status.
Interestingly, a shorter time to ROSC was another 
variable associated with lymphopaenia. We may have 
expected that the severity of the ischaemic injury, which 
is related to the longer duration of CPR, would have been 
associated with more severe apoptosis of T cells and have 
induced a low lymphocyte count in this setting. In stroke, 
although ischaemic cerebral damage may lead to suppres-
sion of peripheral immune responses, which predisposes 
to infection, no association was found between the exten-
sion of the infarct area and functional immune alterations 
[36]. The higher prevalence of IHCA in the lymphopae-
nia group with a shorter intervention time and CPR may 
also explain this finding. Additional studies should evalu-
ate the complex interplay between pre-existing comorbid 
conditions and acute cerebral injury and the development 
of altered immune responses in CA patients.
There was no independent association between lympho-
paenia and poor outcome. In patients with sepsis and sep-
tic shock, a low lymphocyte count was a strong predictor 
of poor outcome, even better than increased neutrophil 
cells [12]. Although sepsis has many common features 
with the PCAS, lymphocyte count and function may play 
a marginal prognostic role in CA survivors. One possible 
explanation could be that the severity of the initial anoxic 
brain injury (i.e. bystander CPR and time to ROSC) was 
not correlated with the occurrence of lymphopaenia. 
Moreover, many patients died within the first 2–3  days 
after arrest because of significant cardiovascular impair-
ment or extended post-anoxic brain injury [37], limiting 
the impact of lymphopaenia on the occurrence of second-
ary infections or delayed organ dysfunction. Neverthe-
less, we observed that in the subgroup of OHCA patients, 
lymphopaenia on admission was associated with UO. This 
suggests that factors as the underlying different causes of 
the arrest between IHCA or OHCA or the management 
of CPR according to arrest location (i.e. different response 
time and quality of CPR) are an important determinant of 
biological biomarkers of poor prognosis and that routine 
monitor of the lymphocyte count in OHCA patients could 
be considered. However, future research should focus on 
a better characterisation of lymphocytes sub-populations, 
in relationship with other biomarker of “immunosuppres-
sion” (i.e. HLA-DR on monocytes) to better understand 
the potential prognostic and therapeutic role of lympho-
paenia in this patients’ population.
Our study has some limitations. Firstly, it was a retro-
spective, single-centre study, which may limit the gen-
eralisability of our conclusions; this can, however, also 
be an advantage, as patients were treated according to a 
local protocol of PCAS management, thus reducing het-
erogeneity. Secondly, we did not record the exact time 
of no flow or the quality of CPR, which may influence 
the inflammatory response after reperfusion. Thirdly, all 
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patients were treated with TTM so that we cannot draw 
any conclusions on lymphopaenia in normothermic CA 
patients or on the effects of TTM use, which may blunt 
the inflammatory response after rewarming, on the 
impact of lymphopaenia. Forth, causes of CA and lym-
phopaenia may differ between IHCA and OHCA. Also, 
it is possible that lymphopaenia may have preceded the 
arrest in some CA victims, such as in case of IHCA. 
Although location of arrest was not a significant predic-
tor of lymphopaenia in our study, this might also be due 
to a lack of power and this question should be further 
addressed in future larger cohorts. Fifth, some patients, 
especially if suffering from IHCA, may have sepsis prior 
to ICU admission, and this could have been a significant 
trigger to lymphopaenia. Unfortunately, sepsis is widely 
under-recognised outside the ICU, so that this variable 
could not be reliably assessed in our database. Finally, 
we perform a multivariate model to identify variables 
associated with the occurrence of lymphopaenia, but we 
did not specifically investigate the lymphocyte count as 
a continuous variable. Although this might appear more 
appropriate, clinicians would be more interested in the 
presence of a “lymphopaenia”, its related risk factors and 
potential consequences rather than considering the abso-
lute lymphocytes count.
Conclusions
Lymphopaenia is a common finding in CA survivors, in 
particular among those with an initial non-shockable 
rhythm, in-hospital CA and previous immunosuppres-
sive therapy. A lower lymphocyte count on admission 
was associated with poor outcome, but was not an inde-
pendent predictor of mortality or neurological recovery. 
Future studies should better characterise the immune 
response in patients resuscitated after CA to improve 
understanding of the pathophysiology of these findings 
and their potential therapeutic interventions.
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